Press Releases, p.2

Thu Sep 2 12:18:06 2010
(Celsion Corporation)
Celsion Receives SBIR Grant To Expand Its Technology Platform

Thu Sep 2 10:24:07 2010
(The Debiopharm Group)
Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010

Thu Sep 2 08:30:07 2010
(Shenzhen Beike Biotechnology Company, Ltd.)
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments

Thu Sep 2 06:36:20 2010
(EUCODIS Bioscience)
EUCODIS Bioscience Appoints Two Industry Executives to Realigned Advisory Board

Thu Sep 2 06:36:16 2010
(Wise Sky (Hong Kong) Limited)
Wise Sky Highlights Their Disappointment at Emergent's Decision Not to Enter the China Market

Thu Sep 2 06:36:08 2010
(MarketsandMarkets)
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports

Thu Sep 2 04:42:23 2010
(Halozyme Therapeutics, Inc.)
Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro and Aspart With rHuPH20 in Type 1 and Type 2 Diabetes

Thu Sep 2 04:42:16 2010
(Oncolytics Biotech Inc.)
Oncolytics Biotech(R) Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute

Thu Sep 2 04:42:12 2010
(MarketsandMarkets)
Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Now Available at ReportsandReports

Thu Sep 2 04:42:07 2010
(Cepheid; FIND)
New England Journal of Medicine Study Reports Xpert MTB/RIF a Faster, More Sensitive & Specific Test for Tuberculosis (TB) Than Current World Standards

Thu Sep 2 00:54:11 2010
(Orexigen Therapeutics, Inc.)
Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America

Wed Sep 1 23:00:12 2010
(Sigma-Aldrich)
Sigma® Life Science Enters Genetically Modified Cell Market

Wed Sep 1 15:24:07 2010
(FIND (Foundation for Innovative New Diagnostics))
New England Journal of Medicine Study Shows New Molecular TB Test Could Offer Rapid and Effective Diagnosis in Developing Countries

Wed Sep 1 13:30:17 2010
(TriMark Publications, LLC)
Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014

Wed Sep 1 11:36:47 2010
(Alzheimer's Research Foundation)
Fisher Scientists Discover Protein that Fuels Alzheimer's Disease, Promising New Treatments Expected

Wed Sep 1 11:36:19 2010
(Association of Medical Media)
AMM Announces The Doctors' Choice Awards Finalists: Over 4,600 MDs Vote for Best Journal Ads in AMM's Doctors' Choice Awards

Wed Sep 1 11:36:11 2010
(The Leukemia & Lymphoma Society - Greater San Francisco Bay Area Chapter)
Four-Time America's Cup Winner Russell Coutts to Open 2010 Leukemia Cup Regatta Weekend

Wed Sep 1 09:42:14 2010
(Eli Lilly and Company)
U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014

Wed Sep 1 09:42:12 2010
(Harborside Press)
The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer

Wed Sep 1 07:48:05 2010
(Abbott)
Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment

Wed Sep 1 05:54:19 2010
(Accumetrics, Inc.)
Accumetrics Increases Capital Raise, Completes Final Close in $24 Million Capital Financing

Wed Sep 1 05:54:14 2010
(Pfizer Inc.)
Pfizer to Acquire FoldRx Pharmaceuticals

Wed Sep 1 05:54:07 2010
(Optimer Pharmaceuticals, Inc.)
Optimer Pharmaceuticals to Present at September 2010 Investor Conferences

Wed Sep 1 05:54:04 2010
(Celator Pharmaceuticals)
Celator® Pharmaceuticals Raises $20 Million in Series D Financing

Wed Sep 1 04:00:08 2010
(Children's Rare Disease Network; The Global Genes Project)
The Global Genes Project Aims to Battle Rare Disease Through the 'Vote4Hope' Campaign and Pepsi Refresh Competition

Wed Sep 1 02:06:14 2010
(EUSA Pharma)
EUSA Pharma Announces the Appointment of Stephen A. Stamp to its Board of Directors

Wed Sep 1 02:06:11 2010
(Cord Blood America, Inc.)
Cord Blood America Says Placenta Collection Services Increasing Revenues in Third Quarter; July 2010 Top Month in Year; BioCells, Inc. Acquisition Proceeding to September Closing

Tue Aug 31 14:42:04 2010
(Cepheid)
Cepheid to Webcast Upcoming Financial Presentations

Tue Aug 31 10:54:32 2010
(Reportlinker)
Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery

Tue Aug 31 10:54:13 2010
(Reportlinker)
Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway

Tue Aug 31 10:54:06 2010
(Reportlinker)
Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017

Tue Aug 31 09:00:40 2010
(Reportlinker)
Reportlinker Adds Drug Delivery Technologies: Players, products & prospects to 2018

Tue Aug 31 09:00:27 2010
(Reportlinker)
Reportlinker Adds Men's Health Therapeutics Market to 2016 - Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market

Tue Aug 31 07:06:03 2010
(Prometheus Laboratories Inc.)
Prometheus Launches the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease

Tue Aug 31 05:12:14 2010
(BioTrends Research Group, Inc.)
Actemra Post-Launch Success Continues to Gain Momentum with Broader Adoption Compared to Biologic Analog Launches and a Professional Marketing Campaign That Resonates with Rheumatologists

Tue Aug 31 05:12:09 2010
(Oncothyreon Inc.)
ONCOTHYREON APPOINTS JULIE M. EASTLAND AS CHIEF FINANCIAL OFFICER

Tue Aug 31 05:12:04 2010
(Halozyme Therapeutics, Inc.)
Halozyme Provides HYLENEX® Product Reintroduction Update

Tue Aug 31 05:12:01 2010
(Repligen Corporation)
Repligen to Present at the Rodman & Renshaw Annual Global Investment Conference

Mon Aug 30 23:30:09 2010
(Amsterdam Molecular Therapeutics B.V)
Amsterdam Molecular Therapeutics Reports Half-Year Results 2010

Mon Aug 30 17:48:12 2010
(Valeant Pharmaceuticals International)
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine

Mon Aug 30 17:48:07 2010
(Bionovo, Inc.)
Bionovo Receives Positive Guidance from FDA on Menerba®

Mon Aug 30 14:00:25 2010
(Aethlon Medical, Inc.)
Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference

Mon Aug 30 14:00:15 2010
(American Heart Association)
Get With The Guidelines-Stroke Program Could Be Global Model

Mon Aug 30 14:00:07 2010
(PriCara(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.)
Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain

Mon Aug 30 12:06:23 2010
(Burrill & Company)
Personalized Medicine: Conference Provides Update on Progress and Prospects

Mon Aug 30 12:06:13 2010
(SomaLogic, Inc.)
NEC and SomaLogic Enter Agreement to Prepare for Delivery of Novel Forms of Health Information via Cloud Services

Mon Aug 30 12:06:08 2010
(Cumberland Pharmaceuticals Inc.)
Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study

Mon Aug 30 08:18:14 2010
(Inspire MD)
InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative

Mon Aug 30 08:18:04 2010
(Sequella, Inc.)
Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology

Mon Aug 30 06:24:17 2010
(Bioheart, Inc.)
Bioheart's MyoCell Recognized as one of the Breakthrough Developments of 2010

Mon Aug 30 06:24:11 2010
(Decision Resources)
For Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabThera's Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent

Mon Aug 30 06:24:06 2010
(BioMarin Pharmaceutical Inc.)
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease

Mon Aug 30 06:24:02 2010
(ThermoGenesis Corp.)
ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market

Mon Aug 30 04:30:14 2010
(Isis Pharmaceuticals, Inc.)
Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010

Sun Aug 29 11:24:16 2010
(Sanofi-aventis)
Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme

Sun Aug 29 11:24:13 2010
(Cincinnati Children's Hospital Medical Center)
Study Points to Key Genetic Driver of Severe Allergic Asthma

Sun Aug 29 05:42:10 2010
(AstraZeneca)
Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients

Fri Aug 27 13:48:08 2010
(Brainware, Inc.)
Major American Health System Automates Accounts Payable with Brainware Distiller

Fri Aug 27 06:12:06 2010
(Novartis Pharmaceuticals Corporation)
Novartis receives FDA approval of Tekamlo™, a single-pill combination of aliskiren and amlodipine to treat high blood pressure

Fri Aug 27 04:18:12 2010
(Athera Biotechnologies AB)
Athera Signs Distribution Agreement in Scandinavia

Fri Aug 27 02:24:15 2010
(Stallergenes)
STALLERGENES: Excellent 1st Half-Year 2010 Performance

Fri Aug 27 02:24:11 2010
(Cord Blood America, Inc.)
Cord Blood America Offers $50,000 Guarantee That Stem Cells It Stores Will Engraft in Transplant Procedure

Thu Aug 26 15:00:12 2010
(Verenium Corporation)
Verenium Appoints Kevin Bracken Vice President of Manufacturing

Thu Aug 26 13:06:14 2010
(Vanda Pharmaceuticals Inc.)
Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock

Thu Aug 26 13:06:10 2010
(Bioheart, Inc.)
Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program

Thu Aug 26 11:12:18 2010
(PG tips)
PG tips Tea is Something to Feel Good About

Thu Aug 26 11:12:08 2010
(Luminex Corporation)
Luminex Announces Commercial Launch of New Cystic Fibrosis Test

Thu Aug 26 11:12:02 2010
(ThermoGenesis Corp.)
ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010

Thu Aug 26 09:18:12 2010
(Shire plc)
Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

Thu Aug 26 07:24:04 2010
(Virgin America)
Virgin America and SU2C Join Forces to Stand Up To Cancer at 35,000 Feet

Thu Aug 26 07:24:01 2010
(Genelex Corporation)
New York State Licenses Personalized Prescribing DNA Tests

Thu Aug 26 05:30:15 2010
(Alexza Pharmaceuticals, Inc.)
Alexza's Staccato® Nicotine Licensed to Cypress Bioscience

Thu Aug 26 05:30:13 2010
(Dr. Larry J. Shapiro)
Hair Loss Expert Says Elin Nordegren is not the Only One Losing Her Hair as a Result of Stress

Thu Aug 26 05:30:08 2010
(Sanofi Pasteur)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers

Thu Aug 26 05:30:05 2010
(BioTrends Research Group, Inc.)
The Availability of Generics, the Desire to Minimize the Use of Steroids and Calcineurin Inhibitors and the Entrance of New Products May Be Driving Shifts in the Management of Kidney Transplant Patients

Wed Aug 25 14:18:08 2010
(Cephalon, Inc.)
Cephalon Announces Chairman and CEO to Take Medical Leave of Absence

Wed Aug 25 12:24:05 2010
(AREVA)
AREVA Med Forms High Level Science Advisory Committee

Wed Aug 25 10:30:07 2010
(Maryland Technology Enterprise Institute)
Mtech Bioprocess Scale-Up Facility to Double in Staff and Size, Expand to Shady Grove, Create Pilot Plant for Biofuels in College Park

Wed Aug 25 08:36:11 2010
(Ambry Genetics)
Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities

Wed Aug 25 06:43:25 2010
(Decision Resources)
Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market

Wed Aug 25 06:43:21 2010
(Fox Chase Cancer Center)
Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome

Wed Aug 25 06:43:16 2010
(NeoStem, Inc.)
NeoStem Comments on Recent Court Ruling Blocking the Federal Government's Funding of Embryonic Stem Cell Research

Wed Aug 25 06:43:06 2010
(Reportlinker)
Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology

Wed Aug 25 06:42:26 2010
(Reportlinker)
Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?

Wed Aug 25 06:42:03 2010
(Reportlinker)
Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline

Wed Aug 25 04:49:51 2010
(Reportlinker)
Reportlinker Adds Analytical Tool - Protein Kinase Inhibitors in Oncology

Wed Aug 25 04:49:48 2010
(Reportlinker)
Reportlinker Adds the Future US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends

Wed Aug 25 04:49:30 2010
(Reportlinker)
Reportlinker Adds US Infectious Disease Testing Market

Wed Aug 25 04:49:19 2010
(Reportlinker)
Reportlinker Adds Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies

Wed Aug 25 04:49:09 2010
(Reportlinker)
Reportlinker Adds Proteins C and S: US, Europe, Japan - Test Volume Forecasts by Country and Market Segment

Wed Aug 25 04:48:50 2010
(Reportlinker)
Reportlinker Adds Advances in Biopharmaceutical Technology in India

Wed Aug 25 04:48:45 2010
(Reportlinker)
Reportlinker Adds Regenerative Medicine Markets

Wed Aug 25 04:48:42 2010
(Arthritis Treatment Center)
Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center

Wed Aug 25 04:48:41 2010
(Jennerex, Inc.)
Jennerex Appoints Lara Longpre to Chief Operating Officer

Wed Aug 25 02:56:17 2010
(Cord Blood America, Inc.)
Cord Blood America CEO Updates Investors on Financial Developments and Stem Cell News in Interview

Tue Aug 24 21:12:13 2010
(Children's Hospital Boston)
Google Search Trends Correlate With Abortion Rates, Policies

Tue Aug 24 21:12:11 2010
(CMC Biologics)
CMC Biologics Completes First Stage of Expansion with Addition of Single-Use Facility

Tue Aug 24 13:36:09 2010
(American Heart Association)
People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal

Tue Aug 24 13:36:03 2010
(BioFortis, Inc.)
BioFortis and Catholic Health Initiatives' Center for Translational Research Announce Biorepository Information Technology Strategic Partnership to Drive Progress in Personalized Medicine

Tue Aug 24 09:48:09 2010
(Shire plc)
Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition